This study employed an in-silico approach to determine pathogenicity of TGFβ-1 and IL-6 gene variants (rs1800470 and rs1800795, respectively) in HCV-induced HCC followed by their validation through allele-specific ARMS-PCR. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.